|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/381 | |
| A61K 47/30 | |||
| A61K 9/08 | |||
| A61K 31/425 | |||
| A61K 31/4045 | |||
| A61P 25/16 |
| (11) | Number of the document | 2773379 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12846647.1 |
| Date of filing the European patent application | 2012-11-01 | |
| (97) | Date of publication of the European application | 2014-09-10 |
| (45) | Date of publication and mention of the grant of the patent | 2019-10-09 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2012/063088 |
| Date | 2012-11-01 |
| (87) | Number | WO 2013/067199 |
| Date | 2013-05-10 |
| (30) | Number | Date | Country code |
| 201161554336 P | 2011-11-01 | US | |
| 201213524994 | 2012-06-15 | US |
| (72) |
MOREADITH, Randall, US
BENTLEY, Michael, David, US
YOON, Kunsang, US
FANG, Zhihao, US
WEIMER, Ribecca, US
DIZMAN, Bekir, US
VIEGAS, Tacey, US
|
| (73) |
Serina Therapeutics, Inc.,
601 Genome Way, Suite 2001, Huntsville, Alabama 35806,
US
|
| (54) | SUBCUTANEOUS DELIVERY OF POLYMER CONJUGATES OF THERAPEUTIC AGENTS |
| SUBCUTANEOUS DELIVERY OF POLYMER CONJUGATES OF THERAPEUTIC AGENTS |